Skip to main content
Top
Published in: Trials 1/2017

Open Access 01-12-2017 | Methodology

Application of Incident Command Structure to clinical trial management in the academic setting: principles and lessons learned

Authors: Penny S. Reynolds, Mary J. Michael, Bruce D. Spiess

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Clinical trial success depends on appropriate management, but practical guidance to trial organisation and planning is lacking. The Incident Command System (ICS) is the ‘gold standard’ management system developed for managing diverse operations in major incident and public health arenas. It enables effective and flexible management through integration of personnel, procedures, resources, and communications within a common hierarchical organisational structure. Conventional ICS organisation consists of five function modules: Command, Planning, Operations, Logistics, and Finance/Administration. Large clinical trials will require a separate Regulatory Administrative arm, and an Information arm, consisting of dedicated data management and information technology staff. We applied ICS principles to organisation and management of the Prehospital Use of Plasma in Traumatic Haemorrhage (PUPTH) trial. This trial was a multidepartmental, multiagency, randomised clinical trial investigating prehospital administration of thawed plasma on mortality and coagulation response in severely injured trauma patients.
We describe the ICS system as it would apply to large clinical trials in general, and the benefits, barriers, and lessons learned in utilising ICS principles to reorganise and coordinate the PUPTH trial.

Results

Without a formal trial management structure, early stages of the trial were characterised by inertia and organisational confusion. Implementing ICS improved organisation, coordination, and communication between multiple agencies and service groups, and greatly streamlined regulatory compliance administration. However, unfamiliarity of clinicians with ICS culture, conflicting resource allocation priorities, and communication bottlenecks were significant barriers.

Conclusions

ICS is a flexible and powerful organisational tool for managing large complex clinical trials. However, for successful implementation the cultural, psychological, and social environment of trial participants must be accounted for, and personnel need to be educated in the basics of ICS.

Trial registration

ClinicalTrials.gov, NCT02303964. Registered on 28 November 2014.
Footnotes
1
The HiPPO acronym (coined by web analytics guru Avinash Kaushik) describes the tendency for decisions to be made on the basis of ‘gut feelings’ or deference of subordinate to more senior personnel.
 
Literature
2.
go back to reference Waring M J, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, Pairaudeau G, Pennie WD, Pickett SD, Wang J, Wallace O, Wei A. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nature Reviews Drug Discovery. Published online 19 June 2015; doi:10.1038/nrd4609 Waring M J, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, Pairaudeau G, Pennie WD, Pickett SD, Wang J, Wallace O, Wei A. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nature Reviews Drug Discovery. Published online 19 June 2015; doi:10.​1038/​nrd4609
3.
go back to reference Buonansegna E, Salomo S, Maier AM, Li-Ying J. Pharmaceutical new product development: why do clinical trials fail? R&D Manag. 2014;44(2):189–202.CrossRef Buonansegna E, Salomo S, Maier AM, Li-Ying J. Pharmaceutical new product development: why do clinical trials fail? R&D Manag. 2014;44(2):189–202.CrossRef
6.
go back to reference Farrell B, Kenyon S, on behalf of the UK Trial Managers’ Network: a guide to efficient trial management. 4th ed. 2014 http://www.tmn.ac.uk/guide Farrell B, Kenyon S, on behalf of the UK Trial Managers’ Network: a guide to efficient trial management. 4th ed. 2014 http://​www.​tmn.​ac.​uk/​guide
8.
go back to reference European Medicines Agency. Guideline For Good Clinical Practice E6(R2). EMA/CHMP/ICH/135/1995. 2016. p. 75. European Medicines Agency. Guideline For Good Clinical Practice E6(R2). EMA/CHMP/ICH/135/1995. 2016. p. 75.
9.
go back to reference Sprague S, Bhandari M. Chap 6. Organization and planning. p 161-185, In: Clinical trials handbook, edited by Shayne Cox Gad. New York: Wiley; 2009. p. 944. Sprague S, Bhandari M. Chap 6. Organization and planning. p 161-185, In: Clinical trials handbook, edited by Shayne Cox Gad. New York: Wiley; 2009. p. 944.
10.
go back to reference Cannon J, Cannon J. Leadership lessons of the Navy Seals. New York: McGraw-Hill Education; 2005. p. 240. Cannon J, Cannon J. Leadership lessons of the Navy Seals. New York: McGraw-Hill Education; 2005. p. 240.
11.
go back to reference Baer AR, Devine S, Beardmore CD, Catalano R. Attributes of exemplary research: clinical investigator responsibilities. J Oncol Pract. 2011;7(2):124–7.CrossRefPubMedPubMedCentral Baer AR, Devine S, Beardmore CD, Catalano R. Attributes of exemplary research: clinical investigator responsibilities. J Oncol Pract. 2011;7(2):124–7.CrossRefPubMedPubMedCentral
12.
go back to reference English R, Lebovitz Y, Griffin R. Transforming clinical research in the United States: challenges and opportunities. Forum on Drug Discovery, Development, and Translation; Institute of Medicine. Washington, D.C: National Academies Press; 2010. p. 150. doi:10.17226/12900. English R, Lebovitz Y, Griffin R. Transforming clinical research in the United States: challenges and opportunities. Forum on Drug Discovery, Development, and Translation; Institute of Medicine. Washington, D.C: National Academies Press; 2010. p. 150. doi:10.​17226/​12900.
13.
go back to reference Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52(12):1143–56.CrossRefPubMed Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52(12):1143–56.CrossRefPubMed
15.
go back to reference Reynolds PS, Michael MJ, Cochran ED, Wegelin JA, Spiess BD. Prehospital use of plasma in traumatic haemorrhage (The PUPTH Trial): study protocol for a randomised controlled trial. Trials. 2015;16:321.CrossRefPubMedPubMedCentral Reynolds PS, Michael MJ, Cochran ED, Wegelin JA, Spiess BD. Prehospital use of plasma in traumatic haemorrhage (The PUPTH Trial): study protocol for a randomised controlled trial. Trials. 2015;16:321.CrossRefPubMedPubMedCentral
20.
go back to reference Adams EH, Scanlon E, Callahan JJ, Carney MT. Utilization of an Incident Command System for a public health threat: West Nile Virus in Nassau County, New York, 2008. J Public Health Manag Pract. 2010;16(4):309–15.CrossRefPubMed Adams EH, Scanlon E, Callahan JJ, Carney MT. Utilization of an Incident Command System for a public health threat: West Nile Virus in Nassau County, New York, 2008. J Public Health Manag Pract. 2010;16(4):309–15.CrossRefPubMed
22.
go back to reference Wiesman J, Melnick A, Bright J, Carreon C, Richards K, Sherrill J, Vines J. Lessons learned from a policy decision to coordinate a multi-jurisdiction H1N1 response with a single incident management team. J Public Health Manag Pract. 2011;17(1):28–35.CrossRefPubMed Wiesman J, Melnick A, Bright J, Carreon C, Richards K, Sherrill J, Vines J. Lessons learned from a policy decision to coordinate a multi-jurisdiction H1N1 response with a single incident management team. J Public Health Manag Pract. 2011;17(1):28–35.CrossRefPubMed
23.
go back to reference Bigley GA, Roberts KH. The Incident Command System: high-reliability organizing for complex and volatile task environments. Acad Manag J. 2001;44(6):1281–99.CrossRef Bigley GA, Roberts KH. The Incident Command System: high-reliability organizing for complex and volatile task environments. Acad Manag J. 2001;44(6):1281–99.CrossRef
25.
go back to reference U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry: E6 (R2) Good Clinical Practice: Consolidated Guidance. 1996. p. 63. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry: E6 (R2) Good Clinical Practice: Consolidated Guidance. 1996. p. 63.
26.
go back to reference U.S. Department of Health and Human Services Food and Drug Administration. Guidance for industry: investigator responsibilities—protecting the rights, safety, and welfare of study subjects. 2009. p. 15. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for industry: investigator responsibilities—protecting the rights, safety, and welfare of study subjects. 2009. p. 15.
27.
go back to reference DeAngelis CD, Fontanarosa PB. Ensuring integrity in industry-sponsored research: Primum non nocere, revisited. JAMA. 2010;303(12):1196–8.CrossRefPubMed DeAngelis CD, Fontanarosa PB. Ensuring integrity in industry-sponsored research: Primum non nocere, revisited. JAMA. 2010;303(12):1196–8.CrossRefPubMed
28.
29.
go back to reference DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005;365:711–22.CrossRef DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005;365:711–22.CrossRef
30.
go back to reference Robinson ET, Baron D, Heise LL, Moffatt J, Harlan SV. Communications handbook for clinical trials: strategies, tips, and tools to manage controversy, convey your message, and disseminate results. Triangle Park: Family Health International, Research Triangle Park; 2011. p. 281. Robinson ET, Baron D, Heise LL, Moffatt J, Harlan SV. Communications handbook for clinical trials: strategies, tips, and tools to manage controversy, convey your message, and disseminate results. Triangle Park: Family Health International, Research Triangle Park; 2011. p. 281.
31.
go back to reference Champion KM, Jones GR. Chap 16. Planning an academic clinical trial. In: Wolfgang Walther and Ulrike Stein, editors. Gene therapy of solid cancers: methods and protocols, methods in molecular biology, vol. 1317. New York: Springer Science + Business Media; 2015. doi:10.1007/978-1-4939-2727-2_16. Champion KM, Jones GR. Chap 16. Planning an academic clinical trial. In: Wolfgang Walther and Ulrike Stein, editors. Gene therapy of solid cancers: methods and protocols, methods in molecular biology, vol. 1317. New York: Springer Science + Business Media; 2015. doi:10.​1007/​978-1-4939-2727-2_​16.
32.
go back to reference Jones CT, Jester PM, FitzGerald M. Issues in research management: protocol challenges in the era of complexity. Res Pract. 2011;12(4):1–11. Jones CT, Jester PM, FitzGerald M. Issues in research management: protocol challenges in the era of complexity. Res Pract. 2011;12(4):1–11.
33.
go back to reference Woodin KE. The CRC’s guide to coordinating clinical research. 2nd ed. Boston: CenterWatch; 2011. p. 611. Woodin KE. The CRC’s guide to coordinating clinical research. 2nd ed. Boston: CenterWatch; 2011. p. 611.
34.
go back to reference Bhardwaj SS, Camacho F, Derrow A, Fleischer Jr AB, Feldman SR. Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology. JAMA Dermatol. 2004;140(12):1520–3.CrossRef Bhardwaj SS, Camacho F, Derrow A, Fleischer Jr AB, Feldman SR. Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology. JAMA Dermatol. 2004;140(12):1520–3.CrossRef
35.
go back to reference Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006;24:4545–52.CrossRefPubMed Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006;24:4545–52.CrossRefPubMed
36.
go back to reference Gygi C, Williams B, DeCarlo N. Mapping to identify possible factors. Ch 7. In: Six Sigma for dummies®. 2nd ed. Hoboken: Wiley; 2012. Gygi C, Williams B, DeCarlo N. Mapping to identify possible factors. Ch 7. In: Six Sigma for dummies®. 2nd ed. Hoboken: Wiley; 2012.
37.
go back to reference NHS Institute for Innovation and Improvement. Improvement leaders’ guides: process mapping, analysis and redesign. Coventry: NHS Institute; 2005. NHS Institute for Innovation and Improvement. Improvement leaders’ guides: process mapping, analysis and redesign. Coventry: NHS Institute; 2005.
40.
go back to reference Freeman S, Williams HC, Dellavalle RP. The increasing importance of systematic reviews in clinical dermatology research and publication. J Investig Dermatol. 2006;126:2357–60.CrossRefPubMed Freeman S, Williams HC, Dellavalle RP. The increasing importance of systematic reviews in clinical dermatology research and publication. J Investig Dermatol. 2006;126:2357–60.CrossRefPubMed
41.
go back to reference Ioannidis JPA. Perfect study, poor evidence: interpretation of biases preceding study design. Semin Hematol. 2008;45:160–6.CrossRefPubMed Ioannidis JPA. Perfect study, poor evidence: interpretation of biases preceding study design. Semin Hematol. 2008;45:160–6.CrossRefPubMed
42.
go back to reference Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DH, Ioannidis JPA, Oliver S. Research: Increasing value, reducing waste 1: how to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65.CrossRefPubMed Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DH, Ioannidis JPA, Oliver S. Research: Increasing value, reducing waste 1: how to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65.CrossRefPubMed
43.
go back to reference FEMA. Handbook for EMS medical directors. Washington DC: United States Fire Administration FA-197; 2012. p. 92. FEMA. Handbook for EMS medical directors. Washington DC: United States Fire Administration FA-197; 2012. p. 92.
Metadata
Title
Application of Incident Command Structure to clinical trial management in the academic setting: principles and lessons learned
Authors
Penny S. Reynolds
Mary J. Michael
Bruce D. Spiess
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1755-9

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue